Xarelto (Rivaroxaban)

XareltoXarelto (Rivaroxaban) is a blood thinner, or anticoagulant, introduced in 2011. It is a huge financial success and created a new generation of anticoagulant medication.

Despite its short time on the market, Xarelto may already be responsible for hundreds of patient deaths. The Food and Drug Administration has linked Xarelto to:

  • 2,081 serious complications in 2012
  • 680 complications in the first quarter of 2013
  • 1,121 deaths reported to the FDA

Media reports also indicate that Xarelto may also be involved in 130 deaths in Germany.

These incidents involve serious and potentially unstoppable bleeding due to the drug’s method of action: preventing the blood from clotting.

If you or a loved one has suffered a serious bleeding incident while taking Xarelto, you need to speak with an experienced pharmaceutical drug attorney today about your options. Contact the Michael Brady Lynch Firm today at (877) 513-9517 for a free consultation.

No Way to Stop Xarelto’s Bleeding

By stopping the blood from clotting, blood-thinners can prevent blood clots in people suffering from conditions such as atrial fibrillation. Due to the risk of unstoppable bleeding, researchers developed an “antidote” to stop this effect in the case of emergency in users of warfarin, the most popular anticoagulant for decades.

Xarelto users aren’t so lucky. There is no antidote to reverse the anti-clotting effect of Xarelto in an emergency. This means doctors and surgeons may have limited options. It means that what could be a treatable injury for most people can be a fatal one for Xarelto users.

Some of the potentially fatal conditions Xarelto users have suffered include:

  • Gastrointestinal bleeding
  • Brain hemorrhaging
  • Kidney bleeding
  • Rectal bleeding
  • Another internal bleeding event

ISMP 2015 Study on Rivaroxaban

Institute For Safe Medication Practices (ISMP) examined all the adverse events submitted to the FDA after patients took Xarelto. They also examined all the adverse events reported to the FDA after patients took the coagulant. Then, they determined that Xarelto failed to prevent pulmonary embolism, caused uncontrollable bleeding, and wasn’t very efficient.

They also determined that:

  • There were 1,121 patient deaths
  • 10,674 reported fatal, disabling or serious injuries
  • 9% involved bleeding cases
  • 9% embolic thrombotic or blood clot events

Exercising Your Rights

If you or a loved one has suffered a serious bleeding incident due to Xarelto – or if such an incident claimed the life of a loved one – you need to contact us today.

Why should you hire an attorney? Because it may be the only way to get you the resources you need to move on with your life.

Nothing can take back what has happened. But it’s very likely this ordeal has placed a huge burden on your family both financially and emotionally. You don’t deserve this, and you need to seek compensation for it.

Not to mention, an attorney can hold the company who made this drug accountable. We may be able to seek compensation for:

  • Ambulance rides, hospital stays, medical tests and procedures
  • Future treatments
  • Lost wages
  • Pain and suffering
  • Loss of companionship and income, if a loved one has died

Trial Update

Currently, the second of four Bellwether trials are being presented in the U.S. District Court, Eastern District of Lousiana.

Contact Us

Therefore, call the Michael Brady Lynch Firm today if a Xarelto bleeding incident has hurt you or a loved one. Michael Lynch has devoted his career to helping people like you.

Consultations are always free and without obligation, so let us tell you what we can do to help you and your family. Call us at (877) 513-9517 or fill out the form on this page to get in touch with us.

Learn More

Judge Rules Bayer Could Have Changed Xarelto Label

Xarelto & Pradaxa Manufacturers Spent Millions Bribing Doctors

Many Receiving Xarelto Overdose

Second Xarelto Bellwether Trial Underway

New Study Suggests Xarelto Causes More Bleeding Than Even Pradaxa

Xarelto Trial Update: Week One Recap

Xarelto Bellwether Trial Begins in New Orleans

Attorney Michael Brady Lynch Lecturers on Pradaxa, Xarelto and Eliquis Litigations

Xarelto May Cause Dementia in AFib Patients

Manufacturers Testing Xarelto for 10 Additional Uses

Xarelto Cases Heading to Trial

Xarelto Approval Trial Skewed by Faulty Blood Monitor

Corporate Greed and the Saga of Xarelto and Pradaxa

Xarelto Cases Consolidated in New Orleans

Xarelto MDL Petition Filed Requesting Consolidation in the Southern District of Illinois

Xarelto Internal Bleeding Dangers on the Rise


Contact Us Today

Contact our lawyers directly through the email form below.
  • * Denotes a required field
  • This field is for validation purposes and should be left unchanged.